πŸ‡ΊπŸ‡Έ FDA
Patent

US 12187754

LpxC inhibitors and uses thereof

granted A61KA61K31/675A61P

Quick answer

US patent 12187754 (LpxC inhibitors and uses thereof) held by BLACKSMITH MEDICINES, INC. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BLACKSMITH MEDICINES, INC.
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/675, A61P, A61P13/02, A61P31/04